SCHEMBL7211920

SCHEMBL7211920

Cc1cc2cccc([C@@H](CO[Si](C)(C)C(C)(C)C)OS(C)(=O)=O)c2nc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.38
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE1C Q14123 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211918 1.00 PDE10A (0.38) PDE10APDE1APDE1BPDE1CATM
SCHEMBL7215272 0.82 PDE10A (0.39) PDE10APDE1APDE1BPDE1CATM
SCHEMBL7215268 0.82 PDE10A (0.39) PDE10APDE1APDE1BPDE1CATM
SCHEMBL719092 0.73 CYP24A1 (0.35) ATM
SCHEMBL7210537 0.72 MAPT (0.32) PDE10APDE1APDE1BPDE1C
SCHEMBL7210539 0.72 MAPT (0.32) PDE10APDE1APDE1BPDE1C
SCHEMBL15260685 0.71 APLNR (0.32)
SCHEMBL15260687 0.71 APLNR (0.32)
SCHEMBL7779987 0.68 MEN1 (0.33) ATM
SCHEMBL17320974 0.67 ELANE (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6617336-B1 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders SANOFI-SYNTHELABO (FR) 2003-09-09 US disclosed
EP-1240146-A1 2-ARYLQUINOLINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-SYNTHELABO (FR) 2002-09-18 EP disclosed
WO-2001038310-A1 2-ARYLQUINOLINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-SYNTHELABO (FR) 2001-05-31 WO disclosed